Current Medical Research and Opinion, Volume 26, Issue 11 (2010)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Current Medical Research and Opinion, Volume 26, Issue 11 (2010)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Vol 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Vol 29, 2013 Vol 28, 2012 Vol 27, 2011 Volume 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Original Article

Article
Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin
Shonda A. Foster, Albert Whangbo, Beth Mitchell, David Muram, John L. Mershon, Rishi Kar & Ganesh Vedarajan
Pages: 2521-2526
Published online: 15 Sep 2010
AbstractforPatient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitonin | Full Text | References | PDF (103.5 KB)
  • 99 Views
  • 2 CrossRef citations
  • 0Altmetric

Brief Report

Brief Report
Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
Richard Pavkov, Stefan Mueller, Katrin Fiebich, Dilraj Singh, Frank Stowasser, Giovanni Pignatelli, Benoît Walter, Dominik Ziegler, Mukul Dalvi, Juergen Dederichs & Ilse Rietveld
Pages: 2527-2533
Published online: 15 Sep 2010
AbstractforCharacteristics of a capsule based dry powder inhaler for the delivery of indacaterol | Full Text | References | PDF (281.4 KB)
  • 3180 Views
  • 76 CrossRef citations
  • 0Altmetric

Original Article

Article
Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment
Julia Carolin Stingl (formerly Kirchheiner), Sumit Parmar, Ariana Huber-Wechselberger, Alexander Kainz, Wilfried Renner, Angela Seeringer, Jürgen Brockmöller, Uwe Langsenlehner, Peter Krippl & Elisabeth Haschke-Becher
Pages: 2535-2542
Published online: 17 Sep 2010
AbstractforImpact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment | Full Text | References | PDF (297.7 KB)
  • 300 Views
  • 29 CrossRef citations
  • 0Altmetric
Article
Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE study
Francesco Locatelli, Kai-Uwe Eckardt, Iain C. Macdougall, Dimitrios Tsakiris, Naomi Clyne, Hans-Ulrich Burger, Armin Scherhag, Tilman B. Drüeke, on behalf of the Cardiovascular Risk Reduction in Early Anaemia Trial with Epoetin Beta (CREATE) investigators and coordinators & on behalf of the Cardiovascular Risk Reduction in Early Anaemia Trial with Epoetin Beta (CREATE) investigators and coordinators
Pages: 2543-2552
Published online: 17 Sep 2010
AbstractforValue of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE study | Full Text | References | PDF (393.8 KB)
  • 202 Views
  • 8 CrossRef citations
  • 0Altmetric

Review

Review Article
Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis
M.-L. Brandi
Pages: 2553-2563
Published online: 21 Sep 2010
AbstractforSustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis | Full Text | References | PDF (138.7 KB)
  • 224 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Article

Article
Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands
Rahul Sasané, Paul Hodgkins & Willemijn Meijer
Pages: 2565-2574
Published online: 23 Sep 2010
AbstractforTreatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands | Full Text | References | PDF (324.6 KB)
  • 201 Views
  • 4 CrossRef citations
  • 0Altmetric

Commentary

Article Commentary
Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma
Ingrida Januleviciene
Pages: 2575-2578
Published online: 27 Sep 2010
AbstractforBrinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma | Full Text | References | PDF (84.2 KB)
  • 262 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Article

Article
Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis
Antonio Crucitti, Qi Zhang, Mary Nilsson, Stephan Brecht, Charles R. Yang & Joachim Wernicke
Pages: 2579-2588
Published online: 27 Sep 2010
AbstractforDuloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis | Full Text | References | PDF (166.8 KB)
  • 439 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
J. Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, Raul D. Santos, Juan Verdejo, David D. Waters, Michael Messig, Lisa Tarasenko, on behalf of the L-TAP 2 Investigators & on behalf of the L-TAP 2 Investigators
Pages: 2589-2597
Published online: 29 Sep 2010
AbstractforLipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2 | Full Text | References | PDF (172.5 KB)
  • 110 Views
  • 17 CrossRef citations
  • 0Altmetric

Brief Report

Brief Report
Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis
Michael Iskedjian, Hania Szajewska, Jörg Spieldenner, Bechara Farah & Jade Berbari
Pages: 2599-2606
Published online: 06 Oct 2010
AbstractforMeta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis | Full Text | References | PDF (268.9 KB)
  • 325 Views
  • 21 CrossRef citations
  • 0Altmetric

Original Article

Article
Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children
Michael Iskedjian, Christophe Dupont, Jörg Spieldenner, Gisèle Kanny, Françoise Raynaud, Bechara Farah & Ferdinand Haschke
Pages: 2607-2626
Published online: 06 Oct 2010
AbstractforEconomic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children | Full Text | References | PDF (926.5 KB)
  • 203 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study
José R. Zanchetta, Cesar E. Bogado, Carlo Cisari, Spyros Aslanidis, Hanna Greisen, John Fox & Willem Lems
Pages: 2627-2633
Published online: 05 Oct 2010
AbstractforTreatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study | Full Text | References | PDF (178 KB)
  • 228 Views
  • 12 CrossRef citations
  • 0Altmetric

Brief Review

Review Article
Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?
Abhishek Deshpande, Vinay Pasupuleti, Chaitanya Pant, Geraldine Hall & Anil Jain
Pages: 2635-2641
Published online: 05 Oct 2010
AbstractforPotential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay? | Full Text | References | PDF (174 KB)
  • 213 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Article

Article
Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials
Beth A. Pangallo, Qi Zhang, Durisala Desaiah, David G.S. Perahia, Michael J. Detke & Sidney H. Kennedy
Pages: 2643-2651
Published online: 11 Oct 2010
AbstractforLong-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials | Full Text | References | PDF (169.8 KB)
  • 395 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia
I. Ray-Coquard, P. Laplaige, N. Vey, B. Asselain & M. Urbieta
Pages: 2653-2660
Published online: 11 Oct 2010
AbstractforA prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia | Full Text | References | PDF (151.5 KB)
  • 69 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study
Denis Moro-Sibilot, Alain Vergnenegre, Egbert F. Smit, Elisabeth Toy, Barbara Parente, Stephan Schmitz, Kees Kraaij, Carla Visseren-Grul, Victoria Soldatenkova, Jorge Arellano & Claudia Leteneux
Pages: 2661-2672
Published online: 14 Oct 2010
AbstractforSecond-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study | Full Text | References | PDF (403.7 KB)
  • 310 Views
  • 15 CrossRef citations
  • 0Altmetric

Brief Report

Brief Report
Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding
Andrea S. Lukes, Ken Muse, Holly E. Richter, Keith A. Moore & Donald L. Patrick
Pages: 2673-2678
Published online: 13 Oct 2010
AbstractforEstimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding | Full Text | References | PDF (133.7 KB)
  • 360 Views
  • 29 CrossRef citations
  • 0Altmetric

Original Article

Article
Estimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population
Amit Sharma, Jerry Yee, Shravanthi R. Gandra, Irfan Khan & Jeffrey Petersen
Pages: 2679-2687
Published online: 13 Oct 2010
AbstractforEstimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population | Full Text | References | PDF (277.8 KB)
  • 342 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
A double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea
Ronald Eccles, Amanda Holbrook & Martez Jawad
Pages: 2689-2699
Published online: 13 Oct 2010
AbstractforA double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea | Full Text | References | PDF (266.9 KB)
  • 691 Views
  • 15 CrossRef citations
  • 0Altmetric

Editorial

Editorial
Primary prevention using statins: to be or not to be?
Lars H. Breimer & D.P. Mikhailidis
Pages: 2701-2706
Published online: 18 Oct 2010
First Page PreviewforPrimary prevention using statins: to be or not to be? | Full Text | References | PDF (105.2 KB)
  • 671 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles